Lorundrostat Stands a Chance Against Obesity-Related Hypertension
(MedPage Today) -- Among selected people with uncontrolled hypertension, blood pressure (BP) could be successfully reduced with a highly selective aldosterone synthase inhibitor, a phase II dose-finding trial found.
In hypertensive patients with...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Eating Disorders & Weight Management | Heart | Hypertension | Obesity